2020 World AIDS Day Report Graphs Tables en
2020 World AIDS Day Report Graphs Tables en
| 2020
INTRODUCTION
AND SUMMARY
1 500 000
Number
of new HIV
infections
1 000 000
800 000
Number of
AIDS-related 600 000
deaths
400 000
200 000
Source: Special analysis by Avenir Health using 2025 targets
and UNAIDS epidemiological estimates, 2020
(https://aidsinfo.unaids.org/) (see annex on methods). 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Number of people living with HIV accessing antiretroviral therapy,
global, 2010–June 2020 and end–2020 target
2020 target
30
25
20
Number of
people 13 26 million people
(millions)
on HIV treatment
10 worldwide in
June 2020
5
0
Jun. Dec.
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2020
Source: UNAIDS 2020 estimates; UNAIDS Global AIDS Monitoring, 2020 (https://aidsinfo.unaids.org/); UNAIDS/WHO/UNICEF HIV services tracking tool, November 2020.
GLOBAL AIDS WORLD AIDS DAY REPORT | 2020
THE FAST-TRACK
LEGACY—SUCCESSES
AND SHORTCOMINGS
1 2 3 4 5
Ensure that 30 million people living with HIV Eliminate new HIV infections among children Ensure access to combination prevention Eliminate gender inequalities and end all Ensure that 90% of young people have the
have access to treatment through meeting the by 2020 while ensuring that 1.6 million options, including preexposure prophylaxis, forms of violence and discrimination against skills, knowledge and capacity to protect
90–90–90 targets by 2020. children have access to HIV treatment by voluntary medical male circumcision, harm women and girls, people living with HIV and themselves from HIV and that they access to
2018 and reduction and condoms, to at least 90% of key populations by 2020. sexual and reproductive health services by
1.4 million by 2020. people by 2020, especially young women and 2020, in order to reduce the number of new
adolescent girls in high HIV-prevalence HIV infections among adolescent girls
countries and key populations—gay men and and young women to below 100 000 per year.
other men who have sex with men,
transgender people, sex workers and their
clients, people who inject drugs and prisoners.
6 7 8 9 10
Ensure that 75% of people living with, at risk of Ensure that at least 30% of all service delivery Ensure that HIV investments increase to Empower people living with, at risk of and Commit to taking AIDS out of isolation through
and affected by HIV benefit from HIV-sensitive is community-led by 2020. US$ 26 billion by 2020, including a quarter for affected by HIV to know their rights and to people-centred systems to improve universal
social protection by 2020. HIV prevention and 6% for social enablers. access justice and legal services to prevent health coverage, including treatment for
and challenge violations of human rights. tuberculosis, cervical cancer and hepatitis B
and C.
New HIV infections projected through 2020, and modelled prediction
resulting from Fast-Track interventions, global, 2010–2020
2 500 000
3.5 million more new infections
from 2015 to 2020 than if the Fast-Track
2 000 000 objectives had been met
1 500 000
Number
of new
infections
1 000 000
500 000
0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Source: Special analysis by Avenir Health using UNAIDS epidemiological estimates, 2020 (see https://aidsinfo.unaids.org/).
AIDS-related deaths projected through 2020, and modelled prediction
resulting from Fast-Track interventions, global, 2010–2020
1 400 000
820 000 more deaths from
1 200 000
2015 to 2020 than if the Fast-Track
objectives had been met
1 000 000
800 000
Number
of deaths
600 000
400 000
200 000
0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Note: Methods for the estimation of
AIDS-related mortality have been
improved since 2016. As a result, the
Actual trend Projected Fast-Track most recent estimates for AIDS-
related mortality (orange line) are
lower before 2016 than the estimates
that were used to calculate the 2020
Source: Special analysis by Avenir Health using UNAIDS epidemiological estimates, 2020 (see https://aidsinfo.unaids.org/). targets (green dotted line).
Percentage change in HIV incidence among key populations, global, 2010–2019
40
+25%
20
+5%
0
-7% -5%
-20
Change in
incidence,
per cent -40
-60
2020 target = 75% reduction
-80
-100
Female sex People who Gay men and Transgender
workers inject drugs other men who people
have sex with
men
Greece
Kyrgyzstan
Ability to obtain antiretroviral therapy
conditional on the use of certain Congo
forms of contraception
Kazakhstan
Health-care professional has ever
told other people about their HIV
Tajikistan
status without their consent Burundi
Forced to submit to a medical or Côte d'Ivoire
health procedure (including HIV
testing) because of their HIV status Costa Rica
in the past 12 months South Korea
Denied health services because of Peru
their HIV status at least once in the
last 12 months Honduras
Malawi
Zimbabwe
0 5 10 15 20 25 30 35 40 45 50
Per cent
100
90
80
70
60
Per cent
50
40
30
20
10
71 74 77 79 81 49 54 59 62 67 41 46 51 54 59
0
People living with HIV People living with HIV People living with HIV
who know their status who are on treatment who are virally suppressed
90% of key populations everywhere have % of key populations who reported Sex workers: 44%
access to comprehensive prevention receiving at least two prevention services Gay/MSM: 30%
services in the past three months People who inject drugs: 34%
20 billion condoms per year are made % of condom distribution need met 59%
available in low- and middle-income
countries
An additional 25 million young men are % of VMMC target achieved 15 million VMMCs (cumulative since 2016)
voluntarily medically circumcised in 15
countries in Africa between 2016 and 2020
3 million people at high risk access PrEP Number of people on PrEP (global data) 590 000
Source: Global HIV Prevention Coalition special analysis of Global AIDS Monitoring data, 2019 and 2020 (see https://aidsinfo.unaids.org/), and other programmatic data reported by countries
through the Global HIV Prevention Coalition.
Resource availability and key funding sources for HIV in low- and middle-income
countries, 2000–2019, with 2020 resource needs target
28
Resource availability (billion US dollars)
23
18
13
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Domestic (public and private) United States (bilateral) Global Fund Other international Resource needs target
Source: UNAIDS financial estimates, July 2020 (see http://hivfinancial.unaids.org/hivfinancialdashboards.html). Note: Constant 2016 US dollars.
GLOBAL AIDS WORLD AIDS DAY REPORT | 2020
RESPONDING TO AND
LEARNING FROM
COVID-19
Percent 0
change
-5
-10
-15
Haiti Botswana Dominican Peru South Africa
Republic
25 16 3 6
countries reported countries did not countries experienced countries experienced
sufficient monthly experience disruptions of at least one more sustained
data to analyze trends disruptions month and then fully disruptions
rebounded
20
Percent -20
change
-40
-60
-80
-100
Rwanda Uganda South Africa Sierra Leone Lesotho
19 1 2 16
countries reported country did not countries experienced countries
sufficient monthly experience disruptions and then fully experienced sustained
data to analyze trends disruptions rebounded by September disruptions
28 1 6 21
countries reported country did not countries experienced countries experienced
sufficient monthly experience disruptions and then fully more sustained
data to analyze trends disruptions rebounded disruptions
13 1 6 6
countries reported country did not countries experienced countries
sufficient monthly experience disruptions and then fully experienced
data to analyze trends disruptions rebounded by September sustained disruptions
10 1 3 6
countries reported country did not countries experienced countries
sufficient monthly experience disruptions and then fully experienced sustained
data to analyze trends disruptions rebounded by September disruptions
100
Percent 50
change
-0
-50
-100
Cambodia Jamaica Kenya South Africa Honduras Togo
16 2 4 4
countries reported countries did not countries experienced countries experienced
sufficient monthly experience disruptions and then sustained disruptions
data to analyze trends disruptions rebounded through the last reported
month
0
Percent
change
-5
-10
-15
Indonesia Myanmar Armenia Kazakhstan
8 7 1
countries reported countries did not country experienced sustained
sufficient monthly experience significant disruptions through the last
data to analyze trends disruptions reported month
1 800 000
700 000
No disruption
1 600 000
Disruption for 3 months
1 400 000 600 000 Disruption for 6 months
1 200 000
Disruption for 2 years
500 000
1 000 000
600 000 Source: Special analysis by Avenir Health using data from
300 000 UNAIDS/WHO/UNICEF HIV services tracking tool,
400 000 November 2020 and UNAIDS epidemiological estimates,
2020 (https://aidsinfo.unaids.org/). See annex on methods,
200 000 200 000
Note: Several scenarios with different disruption durations
2019 2020 2021 2022 2023 2024 2025 2019 2020 2021 2022 2023 2024 2025
(3 months, 6 months and 2 years) have been modelled.
Based on a UNAIDS review of the impact of COVID-19 on
HIV services, we assumed that during a disruption: (a) the
Additional new HIV infections Additional AIDS-related deaths rate of increase in antiretroviral therapy coverage would be
Three-month disruption 123 000 69 000 half the pre-COVID-19 rate; (b) there would be no VMMC;
(c) 20% of the population would experience a complete
Six-month disruption 142 000 79 000 disruption of services to prevent vertical transmission; and
Two-year disruption 293 000 148 000 (d) there would be no PrEP scale-up.
Scale-up of 3-month dispensing of HIV antiretroviral therapy, all ages and children,
mainland Tanzania, 2019–2020
100
90
80
70
60
Per cent
50
40
30
20
10
0
Sep. Oct. Nov. Dec. Jan. Feb. Mar. Apr. May Jun.
2019 2019 2019 2019 2020 2020 2020 2020 2020 2020
Proportion of eligible people living with HIV receiving multimonth dispensing (all ages)
Proportion receiving multimonth dispensing, aged 5–9 years
Proportion receiving multimonth dispensing aged 10–14 years
Source: PEPFAR Tanzania FY 20 Q3 POART. PEPFAR Implementing Partner meeting. PEPFAR; 22 October 2020.
Number of people receiving antiretroviral Net increase in the number of people receiving
therapy by month, all ages, mainland Tanzania, antiretroviral therapy by month, all ages,
January–June 2020 mainland Tanzania, January–June 2020
20 000
1 300 000
Number
Number
1 260 000
10 000
1 240 000
5 000
1 220 000
1 200 000
Jan. Feb. Mar. Apr. May Jun. Jan. Feb. Mar. Apr. May Jun.
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Source: PEPFAR Tanzania FY 20 Q3 POART. PEPFAR Implementing Partner meeting. PEPFAR; 22 October 2020.
GLOBAL AIDS WORLD AIDS DAY REPORT | 2020
System Development Broader efforts in different sectors that advance the results of the
enablers synergies HIV response. Examples include efforts to end poverty and fulfil
the right to health and other human rights.
Top-line targets for 2025
95–95–95 95% of women of 95% of people at Adoption of people- 10–10–10 targets for removing societal and legal impediments to
testing and reproductive age risk of HIV infection centred and context- an enabling environment that limit access or utilization of HIV
treatment targets have their HIV and use appropriate, specific integrated services.
achieved within all sexual and prioritized, person- approaches that support
subpopulations and reproductive health centred and the achievement of the Less than 10% of Less than 10% of Less than 10% of
age groups. service needs met; effective 2025 HIV targets and countries have people living with women, girls, people
95% of pregnant combination result in at least 90% of punitive legal and HIV and key living with HIV and
and breastfeeding prevention options. people living with HIV and policy environments populations key populations
women living with individuals at heightened that deny or limit experience stigma experience gender
HIV have risk of HIV infection linked access to services. and discrimination. inequality and
suppressed viral to services for other violence.
loads; and 95% of communicable diseases,
HIV-exposed non-communicable
Achieve SDG targets critical to the HIV response (i.e., 1, 2, 3, 4, 5,
children are tested diseases, sexual and
8, 10, 11, 16 and 17) by 2030.
by 2025. gender-based violence,
mental health and other
services they need for their
overall health and well-
being.
Sexual and reproductive health and rights within the 2025 AIDS targets
Decriminalization of same-sex sexual Family planning
relationships STI services
Gender equitable laws and policies Comprehensive sexuality education
Reduction of stigma and discrimination
PRIMARY
PREVENTION
PREVENTION OF
VERTICAL
TRANSMISSION
Detailed testing and treatment targets
95% of people within the subpopulation who are living with HIV know their HIV status
95% of people within the subpopulation who are living with HIV and who know their HIV status are on antiretroviral therapy
95% of people within the subpopulation who are on antiretroviral therapy have suppressed viral loads
Detailed targets for sexual and reproductive health services and eliminating
vertical HIV transmission
Population Target
Women of reproductive age in high HIV prevalence 95% have their HIV prevention and sexual and reproductive health service needs met
settings, within key populations and living with HIV
95% of pregnant women are tested for HIV, syphilis and hepatitis B surface antigen at least once
Pregnant and breastfeeding women and as early as possible. In high HIV burden settings, pregnant and breastfeeding women with
unknown HIV status or who previously tested HIV-negative should be re-tested during late
pregnancy (third trimester) and in the post-partum period.
90% of women living with HIV on antiretroviral therapy before their current pregnancy
Pregnant and breastfeeding women All pregnant women living with HIV are diagnosed and on antiretroviral therapy, and 95% achieve
living with HIV viral suppression before delivery
All breastfeeding women living with HIV are diagnosed and on antiretroviral therapy, and 95%
achieve viral suppression (to be measured at 6–12 months)
95% of HIV-exposed infants receive a virologic test and parents provided the results by age 2
months
Children (aged 0–14 years) 95% of HIV-exposed infants receive a virologic test and parents provided the results after the
cessation of breastfeeding
95–95–95 testing and treatment targets achieved among children living with HIV
Thresholds for the prioritization of HIV prevention methods
Criterion Very high High Moderate and low
Sex workers National adult (15–49 years) HIV >3% >0.3% <0.3%
prevalence
Prisoners National adult (15–49 years) HIV >10% >1% <1%
prevalence
Gay men and other men UNAIDS analysis by country/region Proportion of populations estimated to have Proportion of populations estimated to Proportion of populations estimated to have
who have sex with men incidence have incidence incidence
>3% 0.3–3% <0.3%
Transgender people Mirrors gay men and other men who have Proportion of populations estimated to have Proportion of populations estimated to Proportion of populations estimated to have
sex with men in absence of data incidence have incidence incidence
>3% 0.3–3% <0.3%
People who inject UNAIDS analysis by country/region Low needle–syringe programme and Some needle–syringe programme; High needle–syringe programme coverage
drugs opioid substitution therapy coverage some opioid substitution therapy with adequate needles and syringes per
person who injects drugs; opioid substitution
therapy available
Criterion High and very high Moderate Low
Adolescent girls and Combination of [national or subnational 1–3% incidence >3% 0.3–<1% incidence and high-risk <0.3% incidence
young women incidence in women 15–24 years] AND AND incidence reported behaviour OR
[reported behaviour from DHS or other (>2 high-risk reported OR 0.3–<1% incidence and low-risk reported
partners; or reported STI in previous 12 behaviour 1–3% incidence and low-risk behaviour
months)] reported behaviour
Adolescent boys and Combination of [national or subnational 1–3% incidence >3% 0.3–<1% incidence and high-risk <0.3% incidence
young men incidence in men 15–24 years] AND [reported AND incidence reported behaviour OR
behaviour from DHS or other (>2 partners; or high-risk reported OR 0.3–<1% incidence and low-risk reported
reported STI in previous 12 months)] behaviour 1–3% incidence and low-risk behaviour
reported behaviour
Adults (aged 25 and Combination of [national or subnational 1–3% incidence >3% 0.3–<1% incidence and high-risk <0.3% incidence
older) incidence in adults 25–49 years] AND AND incidence reported behaviour OR
[reported behaviour from DHS or other (>2 high-risk reported OR 0.3–<1% incidence and low-risk reported
partners; or reported STI in previous 12 behaviour 1–3% incidence and low-risk behaviour
months)] reported behaviour
Serodiscordant Estimated number of HIV-negative regular Risk stratification depends on choices within the partnership: choice of timing and regimen of antiretroviral therapy for the HIV-positive
partnerships partners of someone newly starting on partner; choice of behavioural patterns (condoms, frequency of sex); choice of PrEP
treatment
Detailed HIV prevention targets for key populations
Gay men and Prisoners
other men and others
who have People who Transgender in closed
KEY POPULATIONS Sex workers sex with men inject drugs people settings
Condoms/lubricant use at last sex by those not taking PrEP with a -- 95% 95% 95% --
non-regular partner whose HIV viral load status is not known to be
undetectable (includes those who are known to be HIV-negative)
Condom/lubricant use at last sex with a client or non-regular partner 90% -- -- -- 90%
Opioid substitution therapy among people who are opioid dependent -- -- 50% -- --
Regular access to appropriate health system or community-led 90% 90% 90% 90% 100%
services
Access to post-exposure prophylaxis as part of package of risk 90% 90% 90% 90% 90%
assessment and support
Detailed HIV prevention targets for the general population
200 000
2010
2012
2014
2022
2024
2030
2010
2012
2018
2020
2022
2030
2016
2018
2020
2026
2028
2014
2016
2024
2026
2028
Annual new HIV infections, UNAIDS epidemiological estimates, 2020 Annual AIDS-related deaths, UNAIDS epidemiological estimates, 2020
No progress on societal enabler targets No progress on societal enabler targets
Progress towards the societal enabler targets Progress towards the societal enabler targets
Source: Special analysis by Avenir Health using data from UNAIDS/WHO/UNICEF HIV services tracking tool, November 2020; and UNAIDS epidemiological estimates, 2020
(https://aidsinfo.unaids.org/). See annex on methods.
Change in HIV incidence over 10 years in countries with favourable and unfavourable
societal environments, by male condom use at last higher risk sex, 2010–2019
40
20
0
Change in
-20
HIV incidence
over 10 years,
%
-40
-60
-80
-100
60 80 95
Most favourable societal environment (75th percentile) Least favourable societal environment (25th percentile)
Source: UNAIDS special analysis using structural equation modelling; see methods annex.
Note: The level of the societal enabling environment is a composite indicator based on four groups of societal enabling environments: (1) gender-equal societies; (2) societies free from stigma and
discrimination; (3) improved access to justice and punitive laws lifted; and (4) joint action with broader development sector. The estimation was performed by applying multivariate panel regression data
with structural equations modeling for the statistical analysis of unobserved constructs.
AIDS-related mortality among people living with HIV by antiretroviral therapy
coverage in countries with favourable and unfavourable societal environments,
2017–2019
3.0
2.5
2.0
AIDS-related
1.5
mortality %
1.0
0.5
0
50 75 90
Most favourable societal environment (75th percentile) Least favourable societal environment (25th percentile)
Source: UNAIDS special analysis using structural equation modelling; see methods annex.
Note: The level of the societal enabling environment is a composite indicator based on four groups of societal enabling environments: (1) gender-equal societies; (2) societies free from stigma and
discrimination; (3) improved access to justice and punitive laws lifted; and (4) joint action with broader development sector. The estimation was performed by applying multivariate panel regression data
with structural equations modeling for the statistical analysis of unobserved constructs.
Countries with discriminatory and punitive laws, global, 2019
32 129 111 92 69
Reporting countries
Countries with punitive laws
Source: UNAIDS National Commitments and Policy Instrument, 2017 and 2019 (see http://lawsandpolicies.unaids.org/); supplemented by additional sources (see references in Annex).
Percentage of people aged 15 to 49 years who report discriminatory attitudes
towards people living with HIV, countries with available data, 2014–2019
100
90
80
70
60
Percent
50
40
30
20
10
0
Nepal
Haiti
Burundi
Mongolia
Suriname
Belize
Zimbabwe
Georgia
Mauritania
Benin
Côte d’Ivoire
Congo
Iraq*
Lao PDR
Malawi
Senegal
Mali
Indonesia
Timor-Leste
India
Thailand
Ethiopia
Angola
Uganda
South Africa
Albania
Armenia
Jordan
Tunisia
Guinea
Gambia
Sierra Leone
Nigeria
Philippines*
Tajikistan*
Madagascar
Kyrgyzstan*
*Data are
for women
aged 15 to
49 only.
Middle East
Eastern and Eastern Europe and North
Asia and the Pacific Caribbean southern Africa and central Asia Africa Western and central Africa
People on the move (migrants, refugees, those in 90% have access to integrated tuberculosis, hepatitis C and HIV services, in addition to IPV programmes, SGBV programmes that include PEP,
emergency contraception and psychological first aid. These integrated services should be person-centred and tailored to the humanitarian
humanitarian settings, etc.) context, the place of settling and the place of origin.
GLOBAL AIDS WORLD AIDS DAY REPORT | 2020
REACHING
THE TARGETS
ANNEX
ON METHODS